Cancer diagnosis with DNA molecular computation

• Published in: Nature nanotechnology Vol. 15; no. 8; pp. 709 - 715
• Main Authors: Zhang, Chao, Zhao, Yumeng, Xu, Xuemei, Xu, Rui, Li, Haowen, Teng, Xiaoyan, Du, Yuzhen, Miao, Yanyan, Lin, Hsiao-chu, Han, Da
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.08.2020; Nature Publishing Group
• Subjects: 631/61/350; 639/638/11; 639/925/926; Biomarkers; Biomarkers, Tumor - blood; Biomarkers, Tumor - genetics; Chemistry and Materials Science; Computation; Computational Biology; Computer applications; Computers, Molecular; Deoxyribonucleic acid; Diagnosis; DNA; Early Detection of Cancer - methods; Gene Expression Profiling - methods; Genomes; Humans; Lung cancer; Lung Neoplasms - diagnosis; Lung Neoplasms - genetics; Lung Neoplasms - metabolism; Materials Science; Medical diagnosis; MicroRNAs; MicroRNAs - blood; MicroRNAs - genetics; miRNA; Nanotechnology; Nanotechnology and Microengineering
• ISSN: 1748-3387; 1748-3395
• DOI: 10.1038/s41565-020-0699-0

Early and precise cancer diagnosis substantially improves patient survival. Recent work has revealed that the levels of multiple microRNAs in serum are informative as biomarkers for the diagnosis of cancers. Here, we designed a DNA molecular computation platform for the analysis of miRNA profiles in clinical serum samples. A computational classifier is first trained in silico using miRNA profiles from The Cancer Genome Atlas. This is followed by a computationally powerful but simple molecular implementation scheme using DNA, as well as an effective in situ amplification and transformation method for miRNA enrichment in serum without perturbing the original variety and quantity information. We successfully achieved rapid and accurate cancer diagnosis using clinical serum samples from 22 healthy people (8) and people with lung cancer (14) with an accuracy of 86.4%. We envision that this DNA computational platform will inspire more clinical applications towards inexpensive, non-invasive and rapid disease screening, classification and progress monitoring. A DNA molecular computation platform allows the rapid diagnosis of lung cancer with high accuracy by analysing specific miRNA levels in clinical serum samples.